Literature DB >> 20812951

Heat-killed and γ-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308.

Naveen Surendran1, Elizabeth M Hiltbold, Bettina Heid, Nammalwar Sriranganathan, Stephen M Boyle, Kurt L Zimmerman, Sharon G Witonsky.   

Abstract

Brucella spp. are Gram-negative, facultative intracellular bacterial pathogens that cause abortion in livestock and undulant fever in humans worldwide. Brucella abortus strain 2308 is a pathogenic strain that affects cattle and humans. Currently, there are no efficacious human vaccines available. However, B. abortus strain RB51, which is approved by the USDA, is a live-attenuated rough vaccine against bovine brucellosis. Live strain RB51 induces protection via CD4(+) and CD8(+) T-cell-mediated immunity. To generate an optimal T-cell response, strong innate immune responses by dendritic cells (DCs) are crucial. Because of safety concerns, the use of live vaccine strain RB51 in humans is limited. Therefore, in this study, we analyzed the differential ability of the same doses of live, heat-killed (HK) and γ-irradiated (IR) strain RB51 in inducing DC activation and function. Smooth strain 2308, live strain RB51 and lipopolysaccharide were used as controls. Studies using mouse bone marrow-derived DCs revealed that, irrespective of viability, strain RB51 induced greater DC activation than smooth strain 2308. Live strain RB51 induced significantly (P≤0.05) higher DC maturation than HK and IR strains, and only live strain RB51-infected DCs (at multiplicity of infection 1:100) induced significant (P≤0.05) tumor necrosis factor-α and interleukin-12 secretion.
© 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812951     DOI: 10.1111/j.1574-695X.2010.00729.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  6 in total

Review 1.  Application of radiation technology in vaccines development.

Authors:  Ho Seong Seo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

2.  Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model.

Authors:  Ayman Al-Mariri; Laila Al-Hallab; Rasha Alabras; Heba Kherbik; Marwa Khawajkiah
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

Review 3.  Ionizing Radiation Technologies for Vaccine Development - A Mini Review.

Authors:  Sohini S Bhatia; Suresh D Pillai
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

Review 4.  Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases.

Authors:  Joaquin Miguel Pellegrini; Jean-Pierre Gorvel; Sylvie Mémet
Journal:  Microorganisms       Date:  2022-06-21

5.  Caspase-2-dependent dendritic cell death, maturation, and priming of T cells in response to Brucella abortus infection.

Authors:  Xinna Li; Yongqun He
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

6.  Brucella discriminates between mouse dendritic cell subsets upon in vitro infection.

Authors:  Alexia Papadopoulos; Aurélie Gagnaire; Clara Degos; Chantal de Chastellier; Jean-Pierre Gorvel
Journal:  Virulence       Date:  2015-11-25       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.